Hospital operator Universal Health Services beat fourth-quarter profit estimates on Wednesday, driven by robust demand for medical care that required hospital stays.
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
OLED reports top-line growth year over year, driven by growing traction in the IT, automotive, smartphone and TV end markets.
Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. Fortunately, they recently enrolled 5,000 subjects in its Phase 2b trial to assess CD388's safety and efficacy. CD388 inhibits viral replication and activates the immune response, and its mechanism of action actually received the FDA's Fast Track designation.
Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in adjusted diluted EPS and improved EBITDA margins, underscores its resilience and efficiency. With COVID disruptions over, UHS is poised for 6%-7% long-term growth, supported by robust performance in both acute and behavioral health segments.
UTI's first-quarter fiscal 2025 results indicate growth in new student starts and average full-time active students at UTI and Concorde.
UTI's first-quarter fiscal 2025 results are likely to reflect growth in average full-time active students. Dive in to get a clear picture ahead of earnings.
Universal Music Group, the world's largest music company, and streaming behemoth Spotify on Sunday announced a multi-year direct deal that will affect both recording and publishing royalty rates.
Spotify and Universal Music Group have struck a new multi-year agreement for recorded music and music publishing “focused on growth, innovation and the advancement of artists' and songwriters' success.
Universal Music Group (UMG) , the world's biggest music label, and Swedish streaming giant Spotify have reached a new multi-year agreement for recorded music and music publishing, they said on Sunday.
Universal garnered 10 Academy Award nominations for "Wicked," a boon for marketing efforts for the second part of the duology, "Wicked: For Good." The film already has pent-up audience demand following a record-breaking box office run both domestically and globally.
Universal Display Corporation remains a fundamentally attractive investment, with a market-leading position in OLED technology and strong partnerships with LG and Samsung. Despite a recent decline in valuation and lowered revenue forecasts, OLED's long-term growth prospects remain solid, driven by increasing adoption and cost efficiencies. The company's current valuation offers a potential upside of 18-22% annualized, making it a compelling "Buy" at around $168/share.